Tabbal, Houda
Septier, Amandine
Mathieu, Mickael
Drelon, Coralie
Rodriguez, Stéphanie
Djari, Cyril
Batisse-Lignier, Marie
Tauveron, Igor
Pointud, Jean-Christophe
Sahut-Barnola, Isabelle
Ragazzon, Bruno
Assié, Guillaume
Bertherat, Jérôme
Lefrançois-Martinez, Anne-Marie
Martinez, Antoine
Val, Pierre
Funding for this research was provided by:
Ligue Contre le Cancer (N/A, N/A)
Worldwide Cancer Research (16-1052)
Fondation ARC pour la Recherche sur le Cancer (PJA-20141201894)
Article History
Received: 7 March 2019
Revised: 3 July 2019
Accepted: 11 July 2019
First Online: 31 July 2019
Competing interests
: The authors declare no competing interests.
: This study used exclusively already published gene expression datasets from anonymised patients. Ethical approval and consent to participate were granted for original studies (refs. <sup>2,3,13</sup>).
: This work was funded by institutional support from Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Clermont Auvergne, La Ligue Contre le Cancer (Allier & Puy de Dôme committees) and Fondation ARC (PJA-20141201894).
: N/A.
: The authors declare that all data supporting the findings of this study are available within the article and its InternalRef removed or from the corresponding author upon reasonable request. Gene expression data from patients cohorts are readily available from GEO (GSE49820 and GSE10927) and Broad GDAC (TCGA ACC data). Mouse gene expression data are available from GEO (GSE109578). ChIP sequencing data were downloaded from GEO and Encode. Details can be found in Supplementary Table InternalRef removed.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).